Save your place

Sign in to WhoBought

Please try again later.

Rigel Pharmaceuticals, Inc. (RIGL) institutional ownership

Latest close $41.88 Jul 10, 2026
Market cap$536M 52-week range SectorHealthcare
Funds holding · Q1 2026
180
reported RIGL position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $8.5M
83 buyers · 97 sellers

Rigel Pharmaceuticals, Inc. (RIGL) price and institutional activity

Dates

Q1 2026

$82M bought by 83 investors
Armistice Capital, LLC$15MAmerican Century Companies Inc$9.7M +81 more
$90M sold by 97 investors
Soleus Capital Management, L.P.-$9.7MHillsdale Investment Management Inc.-$9.5M +95 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Rigel Pharmaceuticals, Inc. (RIGL) institutional activity · 180

Investor Type Est. change Change Δ Own Date
Armistice Capital, LLC · Added +$15M
Change +444K Date Q1 2026
Armistice Capital, LLC Added· Q1 2026 +$15M +444K Q1 2026
Soleus Capital Management, L.P. · Reduced −$9.7M
Change −290K Date Q1 2026
Soleus Capital Management, L.P. Reduced· Q1 2026 −$9.7M −290K Q1 2026
American Century Companies Inc · Added +$9.7M
Change +290K Date Q1 2026
American Century Companies Inc Added· Q1 2026 +$9.7M +290K Q1 2026
Hillsdale Investment Management Inc. · Exited −$9.5M
Change −283K Δ Own −100.0% Date Q1 2026
Hillsdale Investment Management Inc. Exited· Q1 2026 −$9.5M −283K −100.0% Q1 2026
Arrowstreet Capital, Limited Partnership · Reduced −$8.3M
Change −246K Date Q1 2026
Arrowstreet Capital, Limited Partnership Reduced· Q1 2026 −$8.3M −246K Q1 2026
Goldman Sachs Group Inc · Reduced −$7.8M
Change −233K Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −$7.8M −233K Q1 2026
Jane Street Group, LLC · Reduced −$6.9M
Change −206K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −$6.9M −206K Q1 2026
Renaissance Technologies LLC Reduced· Q1 2026 −$6.7M −201K −37.2% Q1 2026
Acadian Asset Management LLC · Added +$5.8M
Change +173K Date Q1 2026
Acadian Asset Management LLC Added· Q1 2026 +$5.8M +173K Q1 2026
Millennium Management LLC · Reduced −$5.6M
Change −167K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −$5.6M −167K Q1 2026
Two Sigma Investments, LP · Added +$4.5M
Change +135K Δ Own +49.6% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +$4.5M +135K +49.6% Q1 2026
Zacks Investment Management · Exited −$4.0M
Change −119K Δ Own −100.0% Date Q1 2026
Zacks Investment Management Exited· Q1 2026 −$4.0M −119K −100.0% Q1 2026
BlackRock · Added +$3.5M
Change +105K Date Q1 2026
BlackRock Added· Q1 2026 +$3.5M +105K Q1 2026
Dimensional · Added +$3.5M
Change +103K Date Q1 2026
Dimensional Added· Q1 2026 +$3.5M +103K Q1 2026
Janus Henderson Group PLC · Added +$3.3M
Change +100K Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +$3.3M +100K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 180

Famous investor activity in Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals, Inc. (RIGL) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Hannah Alison L. · Officer Grant (A) 24K
Owned 35K ΔOwn +229.6% Trade date Jul 8, 2026 Filed date Jul 10, 2026
Hannah Alison L. Officer Grant (A) 24K 35K +229.6% Jul 8, 2026 Jul 10, 2026
Ali-Jackson Kamil · Director Sell −$88K
Price $35.00 Qty −2K Owned 10K ΔOwn −19.8% Trade date Jun 22, 2026 Filed date Jun 24, 2026
Ali-Jackson Kamil Director Sell $35.00 −2K −$88K 10K −19.8% Jun 22, 2026 Jun 24, 2026
Furey Raymond J. · Officer Grant (A) 7K
Owned 7K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Furey Raymond J. Officer Grant (A) 7K 7K Jun 17, 2026 Jun 22, 2026
Rojkjaer Lisa · Officer 2 operations 17K
Owned 7K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Rojkjaer Lisa Officer 2 operations 17K 7K Jun 17, 2026 Jun 22, 2026
Rodriguez Raul R. · Director Grant (A) 32K
Owned 32K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Rodriguez Raul R. Director Grant (A) 32K 32K Jun 17, 2026 Jun 22, 2026
Santos David A. · Officer Grant (A) 7K
Owned 7K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Santos David A. Officer Grant (A) 7K 7K Jun 17, 2026 Jun 22, 2026
Schorno Dean L. · Officer Grant (A) 7K
Owned 7K Trade date Jun 17, 2026 Filed date Jun 22, 2026
Schorno Dean L. Officer Grant (A) 7K 7K Jun 17, 2026 Jun 22, 2026
Schorno Dean L. · CFO 4 operations 0
Price $12.70–$18.70 Owned 14K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Schorno Dean L. CFO 4 operations $12.70–$18.70 0 14K Jun 1, 2026 Jun 3, 2026
Schorno Dean L. · CFO Tax withholding or exercise payment (F) -$28K
Price $29.86 Qty -928 Owned 79K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Schorno Dean L. CFO Tax withholding or exercise payment (F) $29.86 -928 -$28K 79K Jun 1, 2026 Jun 3, 2026
Santos David A. · Officer Tax withholding or exercise payment (F) -$26K
Price $29.86 Qty -874 Owned 62K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Santos David A. Officer Tax withholding or exercise payment (F) $29.86 -874 -$26K 62K Jun 1, 2026 Jun 3, 2026
Rojkjaer Lisa · Officer Tax withholding or exercise payment (F) -$25K
Price $29.86 Qty -850 Owned 34K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Rojkjaer Lisa Officer Tax withholding or exercise payment (F) $29.86 -850 -$25K 34K Jun 1, 2026 Jun 3, 2026
Rodriguez Raul R. · Director Tax withholding or exercise payment (F) -$72K
Price $29.86 Qty -2K Owned 280K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Rodriguez Raul R. Director Tax withholding or exercise payment (F) $29.86 -2K -$72K 280K Jun 1, 2026 Jun 3, 2026
Furey Raymond J. · Officer Tax withholding or exercise payment (F) -$26K
Price $29.86 Qty -877 Owned 51K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Furey Raymond J. Officer Tax withholding or exercise payment (F) $29.86 -877 -$26K 51K Jun 1, 2026 Jun 3, 2026
Ali-Jackson Kamil · Director Sell −$73K
Price $29.17 Qty −2K Owned 13K Trade date May 26, 2026 Filed date May 28, 2026
Ali-Jackson Kamil Director Sell $29.17 −2K −$73K 13K May 26, 2026 May 28, 2026
Wasman Jane · Director Grant (A) 6K
Owned 18K Trade date May 15, 2026 Filed date May 19, 2026
Wasman Jane Director Grant (A) 6K 18K May 15, 2026 May 19, 2026
15 of 46
15 of 46 Sign in to continue to older insider transactions.

Rigel Pharmaceuticals, Inc. (RIGL) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 15.2M
% of shares outstanding 8.7% Filing date Jan 25, 2024
BlackRock Inc. 15.2M 8.7% Jan 25, 2024
Morgan Stanley 14.5M
% of shares outstanding 8.3% Filing date Feb 9, 2024
Morgan Stanley 14.5M 8.3% Feb 9, 2024
Armistice Capital, LLC 1.3M
% of shares outstanding 6.9% Filing date May 15, 2026
Armistice Capital, LLC 1.3M 6.9% May 15, 2026
Invesco Ltd. 1.1M
% of shares outstanding 6.0% Filing date Nov 8, 2024
Invesco Ltd. 1.1M 6.0% Nov 8, 2024
Soleus Capital Master Fund, L.P. 968K
% of shares outstanding 5.2% Filing date May 7, 2026
Soleus Capital Master Fund, L.P. 968K 5.2% May 7, 2026
Vanguard Group Inc 9.0M
% of shares outstanding 5.1% Filing date Feb 13, 2024
Vanguard Group Inc 9.0M 5.1% Feb 13, 2024
Millennium Management LLC 7.6M
% of shares outstanding 4.4% Filing date Sep 22, 2022
Millennium Management LLC 7.6M 4.4% Sep 22, 2022
State Street Corp
% of shares outstanding 1.9% Filing date Feb 6, 2023
State Street Corp 1.9% Feb 6, 2023
8 of 11

Rigel Pharmaceuticals, Inc. (RIGL) ownership FAQ

Who owns RIGL?

180 reporting institutions disclosed RIGL position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.